IntegraGen today announced that it received the 2017 Galien MedStartUp award for “Best Collaboration for a Breakthrough Therapy or Diagnosis” during the recent MedStartUp Days conference held in New York City. IntegraGen was presented the award based on its collaboration with The Solution Lab, a non-profit organization which provides consulting services to life sciences companies, to explore market dynamics and potential strategic approaches to the commercialization of IntegraGen’s Interpretation of Clinical Exome (ICE) software tool in the U.S.

The ICE software is designed to provide a user-friendly approach for the analysis of genomic data and the application of precision medicine approaches to the care of cancer patients.

Click here to view press release.